newsfilter
← Latest News
PR Newswire·

BioVaxys Co-Founder and Chief Medical Officer David Berd, MD, to Present at World Vaccine & Immunotherapy Congress West Coast 2021

VANCOUVER, BC, Nov. 17, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:BIOV), (FRA: 5LB), (OTCQB:BVAXF) ("BioVaxys" or "Company"), a clinical-stage immunotherapy company, announced today that Company Co-Founder and Chief Medical Officer David Ber